ディヒドロプテロ酸合成酵素における触媒と硫黄薬耐性
Mi-Kyung Yun1, Yinan Wu, Zhenmei Li
1Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
まとめ
スルフォナミド抗生物質は,バクテリアのダイヒドロプテロ酸合成酵素 (DHPS) を標的とする. 構造研究は,新しい反応機構を明らかにし,耐性突然変異がどのように発生し,新しい薬の開発に役立つかを説明します.
科学分野:
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
- 微生物学 微生物学とは
背景:
- スルフォナミド抗生物質は,ジヒドロプロテオ酸合成酵素 (DHPS) を標的にすることで,細菌の葉酸合成を阻害するために重要である.
- 新興の耐性変異は,これらの必須抗菌剤の有効性を低下させた.
- DHPSの触媒および抵抗メカニズムを理解することは,効果的な治療戦略の開発に不可欠です.
研究 の 目的:
- ディヒドロプテロ酸合成酵素 (DHPS) の触媒機構と抵抗経路を解明する.
- 主要な反応中間物質を構造的に特徴づけ,基板結合を理解する.
- サルフォナミド耐性の分子基礎を説明するために.
主な方法:
- 酵素運動学と結晶学
- 結晶内の酵素反応
- コンピューティング・モデリング
- サイト・ディレクテッド・ミュータゲネシス (Site-directed mutagenesis) とは
主要な成果:
- DHPS触媒反応中の主要な中間物質の構造的特徴.
- 新種のケチオン性プテリン中間体を含むS(N) 1反応機構を支持する証拠.
- 特定のp-アミノベンゾ酸結合ポケットを形成する保存されたループの識別.
- 保存された活性部位残留機能の説明とスルフォナミド耐性の起源.
結論:
- この研究は,DHPSのための新しい触媒機構を明らかにし,ユニークなカチオン性プテリンの中間物質を含む.
- 構造的な洞察は,保存された活性部位特性が基板結合と触媒にどのように貢献するかを説明します.
- この研究は,サルフォナミド耐性を理解するための分子基盤を提供し,新しい薬剤設計の道を開く.
関連する概念動画
Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme activation, sulfur...
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Phase II Reactions: Miscellaneous Conjugation Reactions
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...

